全文获取类型
收费全文 | 36672篇 |
免费 | 3724篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 476篇 |
儿科学 | 1008篇 |
妇产科学 | 745篇 |
基础医学 | 5242篇 |
口腔科学 | 1367篇 |
临床医学 | 4196篇 |
内科学 | 7303篇 |
皮肤病学 | 402篇 |
神经病学 | 2932篇 |
特种医学 | 1408篇 |
外国民族医学 | 2篇 |
外科学 | 4806篇 |
综合类 | 929篇 |
一般理论 | 30篇 |
预防医学 | 3849篇 |
眼科学 | 1008篇 |
药学 | 2817篇 |
1篇 | |
中国医学 | 27篇 |
肿瘤学 | 1917篇 |
出版年
2021年 | 523篇 |
2020年 | 329篇 |
2019年 | 552篇 |
2018年 | 602篇 |
2017年 | 443篇 |
2016年 | 470篇 |
2015年 | 577篇 |
2014年 | 811篇 |
2013年 | 1213篇 |
2012年 | 1664篇 |
2011年 | 1757篇 |
2010年 | 943篇 |
2009年 | 921篇 |
2008年 | 1541篇 |
2007年 | 1652篇 |
2006年 | 1508篇 |
2005年 | 1586篇 |
2004年 | 1434篇 |
2003年 | 1376篇 |
2002年 | 1351篇 |
2001年 | 1095篇 |
2000年 | 1151篇 |
1999年 | 1070篇 |
1998年 | 407篇 |
1997年 | 335篇 |
1996年 | 392篇 |
1995年 | 350篇 |
1994年 | 344篇 |
1993年 | 350篇 |
1992年 | 861篇 |
1991年 | 840篇 |
1990年 | 873篇 |
1989年 | 791篇 |
1988年 | 751篇 |
1987年 | 754篇 |
1986年 | 697篇 |
1985年 | 718篇 |
1984年 | 532篇 |
1983年 | 492篇 |
1982年 | 319篇 |
1981年 | 323篇 |
1980年 | 294篇 |
1979年 | 473篇 |
1978年 | 378篇 |
1977年 | 310篇 |
1976年 | 299篇 |
1974年 | 374篇 |
1973年 | 361篇 |
1972年 | 297篇 |
1971年 | 311篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Cerebrospinal fluid rhinorrhea in patients with untreated pituitary adenoma: report of two cases 总被引:3,自引:0,他引:3
We report the cases of two patients with untreated pituitary adenoma who presented with cerebrospinal fluid rhinorrhea. The surgical treatment and mechanisms involved in this rare condition are discussed. 相似文献
43.
Studies of the rate of clearance of a gellan gum formulation (Gelrite) radiolabelled by the inclusion of technetium-99m labelled diethylenetriaminepentaacetic acid were carried out in volunteer subjects and in rabbits. Disposition was followed by gamma scintigraphy and compared with 0.5% w/v hydroxyethylcellulose (HEC) solution and isotonic saline administered to the same subjects. Clearance of all solutions was found to follow bi-exponential kinetics with differences in clearance rates between the two species studied. A significant retention of the gellan gum formulation compared to HEC (p = 0.006) or saline (p = 0.009) was noted in man, but not in the rabbit. In this latter species the HEC showed greater retention compared to Gelrite. The species-specific differences in the precorneal residence of the formulations are attributed to the different physiological responses following instillation of solutions into the eye. 相似文献
44.
45.
46.
C M Wilson R J Merritt D W Thomas 《JPEN. Journal of parenteral and enteral nutrition》1988,12(1):81-83
An 11-month-old infant with a central venous catheter for total parenteral nutrition for short gut syndrome developed head and neck swelling. A thrombus at the catheter tip occluding the superior vena cava was demonstrated roentgenographically. A 48-hr infusion of urokinase (4400 units/kg/hr) was administered for thrombolysis. The thrombus cleared clinically and roentgenographically without adverse effects. There has been no recurrence of the superior vena cava syndrome. Urokinase infusion is an alternative to immediate catheter removal in selected patients. 相似文献
47.
G. Singh J. F. Hussain A. MacKinnon C. M. Brown D. A. Kendall V. G. Wilson 《Naunyn-Schmiedeberg's archives of pharmacology》1994,351(1):17-26
In the present study we have prepared crude, methanolic extracts of bovine lung and bovine brain and, using radioligand binding assays in conjunction with a number of simple chromatographic techniques, provided evidence for the presence of a non-catecholamine ’clonidine-displacing substance‘ (CDS). The level of CDS in lung extracts (9?units/g wet weight n=11) is approximately 3 times that in the brain extracts. Furthermore, the effect of the crude, methanolic extracts are selective for non-adrenoceptor, imidazoline (labelled by [ 3H]-idazoxan) and a 2-adrenoceptor binding sites (labelled by [ 3H]-clonidine); both extracts are 5–10-fold more potent displacers of ligand binding to a 2-adrenoceptors compared with binding to opiate receptors (labelled by [ 3H]-etorphine) and practically inactive against a 1-adrenoceptor and muscarinic binding sites (labelled by [ 3H]- prazosin and [ 3H]-quinuclidinyl benzilate, respectively). With the exception of the non-adrenoceptor, imidazoline binding assay, which used rat kidney membranes labelled by [ 3H]-idazoxan in the presence of the a 2-adrenoceptor antagonist RS-15385-197, all radioreceptor assays involved bovine cerebral cortex membranes. Although the extracts contain catecholamines (brain only), histamine (lung only) and monovalent cations (both), which have the potential to interfere with the radioligand binding assays, their concentrations were too low to account for the effects observed. Preliminary attempts at purification of the extracts revealed that CDS activities from the two tissues are similar, i.e., practically insoluble in organic solvents at room temperature, not affected by either Sep-Pak C 18 column or anion exchange resins but retained (along with the monovalent cations) by cation exchange resin. However, following chromatographic separation on a Biogel P2 column, the CDS-containing eluates are cation-free and exhibit qualitatively similar elution profiles. Future experiments will involve further purification of ’clonidine-displacing substance‘ to characterize its interaction with a 2-adrenoceptor binding sites in greater detail and establish whether it has biological activity consistent with the properties implied by its effects in radioligand binding assays. 相似文献
48.
H. -J. Möller H. M. van Praag B. Aufdembrinke P. Bailey T. R. E. Barnes J. Beck H. Bentsen F. X. Eich L. Farrow W. W. Fleischhacker J. Gerlach K. Grafford B. Hentschel A. Hertkorn S. Heylen Y. Lecrubier J. P. Leonard P. McKenna W. Maier V. Pedersen A. Rappard W. Rein J. Ryan M. Sloth Nielsen R. -D. Stieglitz G. Wegener J. Wilson 《Psychopharmacology》1994,115(1-2):221-228
There is little agreement about the methodology of clinical trials of antipsychotic drugs in patients with negative symptoms. A literature review revealed wide variation in experimental design, rating scales and study duration. This reflects differing views as to the definition and response to treatment of negative symptoms. Some degree of standardization would improve comparability of studies and aid the development of new compounds. Patients included in such studies should have displayed negative symptoms for at least 6 months. Depressive symptoms, positive schizophrenic symptoms and extrapyramidal signs may all influence or be confused with negative symptoms and may respond to treatment; they should be at a low level at baseline and should be measured during the study period. Studies should last at least 8 weeks. Several scales are available for measuring negative symptoms and are reviewed; a global impression score should be used additionally. 相似文献
49.
R. J. Rona A. V. Swan R. Beech D. M. Wilson F. B. Kavanagh C. Brown C. Axtell S. Mandalia 《Clinical genetics》1992,42(4):186-195
For certain genetic conditions DNA testing identifies carriers and determines the risk status of foetuses, thus helping parents to make more informed prenatal decisions. Data, collected from three genetic centres in England and Wales from August 1986 to July 1990, are used to describe trends in demand for DNA testing, the impact of DNA tests on carrier risk assessment, and the use of DNA tests in relation to pregnancy outcome. Altogether the data include 23,388 subjects and 681 pregnancies in 8738 families divided into five cohorts by year of entry and referral. The most frequent gene disorders referred to the genetic centres are currently being tested or will soon be tested. For these disorders the initial high level of activity has declined and may have reached steady state. Demand for DNA services is high for cystic fibrosis and Duchenne muscular dystrophy, intermediate for Huntington's disease, and low for adult polycystic kidney disease, phenylketonuria and tuberous sclerosis. Based on these findings we suggest that demand for DNA tests will be high in serious, untreatable and slow progressing conditions with early onset; intermediate for conditions affecting intellect and neurological integrity with later onset; and low for treatable, late-onset conditions, or those for which there is evidence of heterogeneity, and variable penetrance. It would be helpful to assess the extent to which this view of demand is confirmed when the new disorders being DNA tested are considered and for the pattern of activity of DNA testing for some types of cancer. Since no DNA centre could offer a fully comprehensive testing service, it is recommended that a structure is created to audit overall activity, assist in policy formulation, and influence supraregional service organisation, in order that the spread of DNA services be planned as effectively as possible. This structure would facilitate monitoring of the evolution of contract specifications agreed by commissioners and providers on a regional basis. 相似文献
50.
NMDA agonists and antagonists alter the hypnotic response to ethanol in LS and SS mice 总被引:2,自引:0,他引:2
Involvement of glutamate neurotransmission in the differential response of long-sleep (LS) and short-sleep (SS) mice to acute ethanol was examined by measuring the effect of centrally administered glutamate receptor agonists and antagonists on blood ethanol concentration (BEC) at loss of righting response following intragastric administration of ethanol. NMDA coinjected with glycine, and quinolinic acid (QA), decreased sensitivity to ethanol in both lines of mice. SS mice were more sensitive to QA than were LS. The NMDA antagonists 2-amino-5-phosphonovaleric acid (APV), MK-801 and an inhibitor of glutamate synthesis, methionine sulfoximine, increased sensitivity to ethanol in both lines of mice. MK-801 effects were line dependent with SS being more sensitive. In addition, coinjection of APV, Mg++ or Zn++ with QA blocked the decrease in sensitivity seen with QA alone. These results demonstrate that NMDA agonists and antagonists alter the acute hypnotic response to ethanol in both LS and SS mice, and support the hypothesis that ethanol exerts its effects in part by altering glutamatergic neurotransmission. 相似文献